Take the Zacks Approach to Beat the Markets: Philip Morris, IAMGOLD, Solventum in Focus
https://www.zacks.com/stock/news/2333489/take-the-zacks-approach-to-beat-the-markets-philip-morris-iamgold-solventum-in-focus?cid=CS-ZC-FT-analyst_blog|investment_ideas-2333489
Sep 09, 2024 - Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
0
Top Analyst Reports for UnitedHealth, Procter & Gamble & HSBC
https://www.zacks.com/commentary/2330798/top-analyst-reports-for-unitedhealth-procter-gamble-hsbc?cid=CS-ZC-FT-research_daily-2330798
Sep 03, 2024 - Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), The Procter & Gamble Company (PG) and HSBC Holdings plc (HSBC), as well as a micro-cap stock Oil-Dri Corporation of America (ODC).
0
2 Top Healthcare Growth Stocks to Buy Right Now
https://www.fool.com/investing/2024/08/30/2-top-healthcare-growth-stocks-to-buy-right-now/?source=iedfolrf0000001
Aug 30, 2024 - These businesses are profitable and growing steadily.
0
12 Dividend Stocks to Earn Income Every Month
https://www.fool.com/investing/2024/08/28/12-dividend-stocks-to-earn-income-every-month/?source=iedfolrf0000001
Aug 28, 2024 - Get paid a dividend on a monthly basis.
0
Why UnitedHealth Group (UNH) is a Top Stock for the Long-Term
https://www.zacks.com/stock/news/2322989/why-unitedhealth-group-unh-is-a-top-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2322989
Aug 16, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
0
Markets Mixed Ahead of Key Inflation Data
https://www.zacks.com/stock/news/2320986/markets-mixed-ahead-of-key-inflation-data?cid=CS-ZC-FT-ahead_of_wall_street-2320986
Aug 12, 2024 - Tomorrow morning, the Producer Price Index (PPI) will demonstrate levels of wholesale inflation.
0
Bio-Rad (BIO) Faces Low BioPharma Demand, Competitive Pressure
https://www.zacks.com/stock/news/2320781/bio-rad-bio-faces-low-biopharma-demand-competitive-pressure?cid=CS-ZC-FT-analyst_blog|zer_report_update-2320781
Aug 12, 2024 - Bio-Rad (BIO) is experiencing weaker sales in Asia as China is currently entangled in a challenging research funding environment, and Japan, too, is facing constrained funding issues.
0
Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2320641/why-unitedhealth-group-unh-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2320641
Aug 12, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Select Medical's (SEM) Stock Down 16.9% Despite Q2 Earnings Beat
https://www.zacks.com/stock/news/2317297/select-medical-s-sem-stock-down-16-9-despite-q2-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2317297
Aug 06, 2024 - Select Medical (SEM) expects its adjusted EBITDA between $845 million and $885 million for 2024, the mid-point of which implies a 7.1% rise from the 2023 reported figure of $807.4 million.
0
Teladoc Health (TDOC) Shares Down 8.9% Despite Q2 Earnings Beat
https://www.zacks.com/stock/news/2315541/teladoc-health-tdoc-shares-down-8-9-despite-q2-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2315541
Aug 02, 2024 - Teladoc Health (TDOC) expects revenue growth in the Integrated Care segment to be within low to mid-single-digit growth in 2024, on a year-over-year basis.
0